Description     Claims     Drawing  

US61368042B   [0001] 
US3773919A   [0150]  [0176] 
US353270960B   [0150] 
US4624665A   [0168] 
US4655767A   [0168] 
US4687481A   [0168] 
US4797284A   [0168] 
US4810499A   [0168] 
US4834978A   [0168] 
US4877618A   [0168] 
US4880633A   [0168] 
US4917895A   [0168] 
US4927687A   [0168] 
US4956171A   [0168] 
US5035894A   [0168] 
US5091186A   [0168] 
US5163899A   [0168] 
US5232702A   [0168] 
US5234690A   [0168] 
US5273755A   [0168] 
US5273756A   [0168] 
US5308625A   [0168] 
US5356632A   [0168] 
US5358715A   [0168] 
US5372579A   [0168] 
US5421816A   [0168] 
US5466465A   [0168] 
US5494680A   [0168] 
US5505958A   [0168] 
US5554381A   [0168] 
US5560922A   [0168] 
US5585111A   [0168] 
US5656285A   [0168] 
US5667798A   [0168] 
US5698217A   [0168] 
US5741511A   [0168] 
US5747783A   [0168] 
US5770219A   [0168] 
US5814599A   [0168] 
US5817332A   [0168] 
US5833647A   [0168] 
US5879322A   [0168] 
US5906830A   [0168] 
US3845770A   [0173] 
US3916899A   [0173] 
US3536809A   [0173] 
US3598123A   [0173] 
US4008719A   [0173] 
US5674533A   [0173] 
US5059595A   [0173] 
US5591767A   [0173] 
US5120548A   [0173] 
US5073543A   [0173] 
US5639476A   [0173] 
US5354556A   [0173] 
US5733566A   [0173] 
US6365185B1   [0173] 
US4747825A   [0175] 
US4723958A   [0175] 
US4948592A   [0175] 
US4965251A   [0175] 
US5403590A   [0175] 
EP11813107   [0235] 
US2011045526W   [0235] 
WO61368042A   [0235] 

The Merck Manual of Diagnosis and Therapy   [0059] 
The Encyclopedia of Molecular Biology   [0059]  [0059] 
Molecular Biology and Biotechnology: a Comprehensive Desk Reference   [0059] 
Immunology   [0059] 
Genes IX   [0059] 
Molecular Cloning: A Laboratory Manual   [0059] 
Molecular Cloning: A Laboratory Manual   [0059] 
Basic Methods in Molecular Biology   [0059] 
Methods in Enzymology: Guide to Molecular Cloning Techniques   [0059] 
Current Protocols in Molecular Biology (CPMB)   [0059] 
Current Protocols in Protein Science (CPPS)   [0059] 
Current Protocols in Immunology (CPI)   [0059] 
J. Biol. Chem.   [0063] 
EMBO J.   [0063] 
J. Biol. Chem.   [0063] 
J. Biol. Chem.   [0063] 
Mol. Cell. Biol.   [0063] 
J. Biol. Chem.   [0063] 
Annu. Rev. Cell. Dev. Biol.   [0063]  [0063] 
Crit. Rev. Toxicol.   [0063]  [0063] 
Trends in Immunology   [0066]  [0067]  [0068]  [0069] 
Nucleic Acids Res.   [0068] 
Mol. Pharmacol.   [0072]  [0072] 
Mol. Cell. Biol   [0072]  [0072] 
Biochemical Pharmacology   [0072] 
Tetrahedron   [0122] 
Protective Groups in Organic Synthesis   [0122] 
Oligonucleotides And Analogues A Practical Approach   [0122] 
Remington's Pharmaceutical Sciences   [0146]  [0171] 
Ann. Rev. Pharmacol. Toxicol.   [0150] 
Controlled Release of Pesticides and Pharmaceuticals   [0150] 
Remington's Pharmaceutical Sciences   [0153]  [0167]  [0167] 
Drug Stability: Principles & Practice   [0161] 
J. Pharm. Res.   [0166] 
J. Int. J. Pharm.   [0166] 
Aerosols for delivery of therapeutic an diagnostic agents to the respiratory tract   [0166] 
Am. Rev. Respir. Dis.   [0166] 
Advanced Drug Delivery Reviews   [0166] 
Int. J. Pharm.   [0166] 
Spray Technol. Market   [0166] 
Aerosol Sci.   [0166] 
Powder Technology   [0166] 
J. Controlled Release   [0166] 
Biomed. Mater. Res.   [0166] 
Drug Delivery   [0166] 
Adv. Drug Del. Rev.   [0166] 
Adv. Drug. Del. Rev.   [0166] 
Controlled Release   [0166] 
Nature Biotechnology   [0166] 
Pharm. Res.   [0166] 
Pharm. Res.   [0166] 
Introduction to Pharmaceutical Dosage Forms   [0167]  [0167] 
Controlled Release Dosage Form Design   [0172] 
Chem. Intl. Ed. Engl.   [0192] 
Cell cycle regulation, oncogenes, and antineoplastic drugs   [0195] 
Prodrugs in Cancer Chemotherapy   [0196] 
Prodrugs: A Chemical Approach to Targeted Drug Delivery   [0196] 
Comparison of shape-matching and docking as virtual screening tools   [0234] 
Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcription in a rat model of mammary tumorigenesis   [0234] 
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors   [0234] 
Increased expression of MDM2, cyclin D1, and p27(Kip1) in carcinogen-induced rat mammary tumors   [0234] 
The RelA NF-kB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells *Equal contributions   [0234] 
Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A   [0234] 
Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture   [0234] 
A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis   [0234] 
7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB   [0234] 
The aryl hydrocarbon receptor influences human mammary tumor cell invasion   [0234] 
An inhibitory feedback loop mediated by the aryl hydrocarbon receptor and its repressor in human mammary cells   [0234] 
Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype   [0234] 
Constitutive regulation of CYP1 B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue   [0234] 
Constitutively active aryl hydrocarbon receptor (AhR) drives immortalized mammary epithelial cell growth through repression of ChK2 and p21 and CYP1 B1 up-regulation   [0234] 
The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells   [0234] 
NF-kappaB and epithelial to mesenchymal transition of cancer   [0234] 
Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor   [0234] 
ParaFrag--an approach for surface-based similarity comparison of molecular fragments   [0234] 
Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists   [0234] 
The use of local surface properties for molecular superimposition   [0234] 
A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptor   [0234] 
ShaEP: molecular overlay based on shape and electrostatic potential   [0234] 
The bioflavonoid galangin blocks aryl hydrocarbon receptor activation and polycyclic aromatic hydrocarbon-induced pre-B cell apoptosis   [0234] 
Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo   [0234] 
Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice   [0234] 
Cancer Statistics, 1995   [0234] 
Breast cancer   [0234] 
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment   [0234] 
Cancer rates in a community exposed to low levels of creosote components in municipal water   [0234] 
The role of aromatic hydrocarbons in the genesis of breast cancer   [0234] 
A holistic approach to breast cancer   [0234] 
Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk   [0234] 
U.S. Surveillance, Epidemiology, and End Results   [0234] 
Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study   [0234] 
Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies   [0234] 
17 beta¬estradiol hydroxylation catalyzed by human cytochrome P450 1 B1   [0234] 
4-Hydroxylation of estrogens as marker of human mammary tumors   [0234] 
Cytochrome P450 1B1- mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation   [0234] 
Association of CYP1 B1 genetic polymorphism with incidence to breast and lung cancer   [0234] 
Estrogen bioactivation, genetic polymorphisms, and ovarian cancer   [0234] 
Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke   [0234]